Nxera Pharma (SOLTF) News Today

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

$9.72

0.00 (0.00%)

(As of 04/18/2024 ET)

Stock Analysis Analyst Forecasts Chart Headlines Short Interest

Source

Source	Headline
	Nxera Pharma: Notice of Issuance of New Shares Under the Restricted Stock Unit (RSU) Plan and Determination of Payment Amount and Other Matters of Issuance of New Shares Under Previous Years’ RSU Plan finance.yahoo.com - April 17 at 10:23 AM
	Nxera and Handok partner for PIVLAZ supply in South Korea msn.com - April 15 at 3:12 PM
	Nxera Pharma Announces Supply And Distribution Deal With Handok For PIVLAZ In South Korea nasdaq.com - April 15 at 10:12 AM
	Nxera Pharma Announces Exclusive Supply and Distribution Agreement with Handok for PIVLAZ™ in South Korea finance.yahoo.com - April 15 at 12:03 AM
	Nxera Pharma (OTCMKTS:SOLTF) Stock Crosses Above 50 Day Moving Average of $9.99 americanbankingnews.com - April 10 at 4:36 AM
	Nxera Pharma joins the World Orphan Drug Alliance finance.yahoo.com - April 8 at 8:13 AM
	Nxera Pharma Appoints Experienced Senior Strategy Consultant Patrick Branch as Head of Business Development for Japan and APAC finance.yahoo.com - April 3 at 4:06 AM
	Nxera Pharma is the New Name for Sosei Group globenewswire.com - March 31 at 7:30 PM
	Sosei Heptares Confirms Re-election of its Board and Executive Management Team and the Approval of Change of Company Name to Nxera Pharma finance.yahoo.com - March 27 at 8:48 AM
	Sosei Heptares Doses First Subject in Phase 1 Trial with HTL0033744, an EP4 Agonist for Inflammatory Bowel Disease finance.yahoo.com - March 20 at 11:14 PM
	Boehringer Ingelheim and Sosei Heptares join forces to develop first-in-class treatments targeting all symptoms of schizophrenia finance.yahoo.com - March 11 at 4:07 AM
	Sosei Heptares to receive US$2.5 million milestone payment from Formosa Pharmaceuticals finance.yahoo.com - March 6 at 4:26 PM
	Sosei Group Corporation (SOLTF) finance.yahoo.com - March 1 at 8:16 AM
	Sosei Group: Notice of Change of Corporate Name to Nxera Pharma and Change of Location of Head Office globenewswire.com - February 15 at 6:35 PM
	Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2023 finance.yahoo.com - February 13 at 4:19 AM
	Sosei Heptares Webinar Presentation for FY2023 Financial Results finance.yahoo.com - January 22 at 7:58 AM
	Sosei Group Announces Appointment of Experienced Pharmaceutical Executive Toshihiro Maeda as Chief Operating Officer finance.yahoo.com - January 5 at 7:34 AM
	Sosei Heptares to Present at 42nd Annual J.P. Morgan Healthcare Conference finance.yahoo.com - December 21 at 7:47 AM
	Sosei Group Announces Marketing Approval for PIVLAZ™ (clazosentan sodium) 150 mg in South Korea finance.yahoo.com - December 7 at 6:35 AM
	Sosei Heptares’ Partner Neurocrine Biosciences Confirms its Plans to Evaluate Two New Muscarinic Agonist Candidates in Phase 1 Clinical Studies finance.yahoo.com - December 6 at 6:15 AM
	Sosei Heptares to Regain Full Ownership of GSK4381406*, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease finance.yahoo.com - November 24 at 9:32 AM
	Sosei Group Corp 4565 morningstar.com - November 14 at 10:42 AM
	Sosei Group reports Q3 results msn.com - November 10 at 2:53 PM
	Sosei Heptares Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2023 finance.yahoo.com - November 10 at 4:52 AM
	Sosei Heptares and Kallyope Nominate First GPCR Target for Therapeutic Development in Gastrointestinal Diseases finance.yahoo.com - November 10 at 4:52 AM
	Sosei Heptares’ President & CEO and Head of UK R&D to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2023 finance.yahoo.com - November 7 at 7:45 AM
	Sosei Heptares’ Partner, Pfizer, Progresses Its GLP-1 Receptor Agonist PF-06954522 into a Phase 1 Trial finance.yahoo.com - November 5 at 10:33 PM
	Sosei Heptares Announces Submission of New Drug Application in Japan for Daridorexant (ACT-541468), a Dual Orexin Receptor Antagonist for the Treatment of Insomnia finance.yahoo.com - October 31 at 10:06 AM
	Sosei Heptares Will Receive US$3.75 Million Payment in Multi-Target Partnership finance.yahoo.com - October 31 at 10:06 AM
	Sosei Heptares to Host R&D Day Highlighting its Innovative R&D and Late-Stage Development Progress finance.yahoo.com - October 25 at 8:50 AM
	Sosei Heptares’ President & CEO Chris Cargill Wins Executive of the Year at the Citeline Pharma Intelligence Awards Japan 2023 finance.yahoo.com - October 18 at 10:03 AM
	Sosei and PharmEnable collaborate on another neurological drug msn.com - October 10 at 8:33 AM
	Sosei Heptares and Verily Nominate First G-protein-coupled receptor Target for Therapeutic Development finance.yahoo.com - October 4 at 3:29 PM
	Sosei Heptares Adds World-leading Expertise to its Scientific Advisory Board finance.yahoo.com - September 20 at 8:36 AM
	Sosei Heptares and Cancer Research UK Announce the Dosing of the First Patient in a Phase I/IIa Trial with Cancer Immunotherapy Drug HTL0039732 finance.yahoo.com - August 10 at 10:42 AM
	Sosei Heptares Operational Highlights and Consolidated Results for the Second Quarter and First Half of 2023 finance.yahoo.com - August 4 at 6:04 AM
	Sosei buys Idorsia Pharmaceuticals' Japan, Korea units for $466 million - Nikkei reuters.com - July 21 at 2:03 PM
	Sosei Group Shares Indicated Lower After Partner Pfizer Terminates Diabetes Drug Development marketwatch.com - June 27 at 7:56 AM
	Sosei Group (TYO:4565) Price Target Increased by 5.50% to 3,351.43 msn.com - June 3 at 8:06 AM
	Sosei Heptares Confirms Changes to its Board and Executive Management Team at Annual Shareholders’ Meeting finance.yahoo.com - April 5 at 7:49 PM
	Sosei Heptares Receives Approval for Change of Market Listing Segment to the Tokyo Stock Exchange Prime Market finance.yahoo.com - March 18 at 12:29 AM
	Sosei Group Corp reuters.com - December 22 at 12:03 AM
	PrecisionLife to Evaluate Precision Medicine Potential of Sosei Heptares Neuroscience GPCR Target finance.yahoo.com - November 8 at 5:54 AM
	Sosei Group Corp (4565) investing.com - September 17 at 9:25 PM
	EXCLUSIVE \| Ola Electric rejigs roles to unify operations across roles; YS Kim gets larger role msn.com - September 13 at 12:09 PM
	Harford medical centers recognized for heart disease and stroke care by American Heart Association yahoo.com - August 6 at 9:48 PM
	Sosei to get $30M from Neurocrine as schizophrenia drug gets FDA nod to enter phase 2 trial seekingalpha.com - August 6 at 9:48 PM
	Suspect in cyclist’s love triangle murder pleads not guilty yahoo.com - July 23 at 9:13 AM
	Netizens call out NTU students auctioning off their hostel rooms for $900 while they live at home, even as international students struggle to find accommodations msn.com - July 12 at 3:06 AM
	SGI Buddhist Group Amplifies Voices of Youth, Faith Communities and Victims at Meeting of Parties to Nuclear Ban Treaty yahoo.com - June 24 at 6:26 AM

Get Nxera Pharma News Delivered to You Automatically

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

SOLTF Media Mentions By Week

SOLTF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SOLTF
News Sentiment
▼
0.92

0.53
▲
Average
Medical
News Sentiment

SOLTF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SOLTF Articles
This Week
▼
4

0
▲
SOLTF Articles
Average Week

Get Nxera Pharma News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (OTCMKTS:SOLTF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Nxera Pharma (SOLTF) News Today

SOLTF Media Mentions By Week

SOLTF Media Sentiment

SOLTF News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info